Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis and Related Disorders|January 15, 2022
Evaluation of the times of disability progression and related factors in patients with primary progressive multiple sclerosis from ArgentinaRicardo Alonso, Orlando Garcea, Juan Ignacio Rojas, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Rebound activity after fingolimod cessation: A case - control studyAndres Barboza, María Inés Gaitán, Ricardo Alonso, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 11, 2024
Cladribine use trend in Latin America: the changes in patient profile impact in the drug effectivenessBerenice A Silva, Alejandra Heriz, Jeremías Ayerbe, et al.
Multiple Sclerosis and Related Disorders|July 21, 2024
Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM)Edgar Carnero Contentti, Pablo A Lopez, Liliana Patrucco, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 26, 2020
Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM)Ricardo Alonso, Cecilia Quarracino, Bárbara Eizaguirre, et al.
Journal of the Neurological Sciences|October 19, 2025
Efficacy and safety of Cladribine as a therapeutic option in multiple sclerosis patients over 50 years of age: A real-world studyMaría Agustina Piedrabuena, Jorge Correale, Berenice Silva, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 27, 2022
Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in ArgentinaJuan I Rojas, Agustín Pappolla, Liliana Patrucco, et al.
Frontiers in Immunology|September 3, 2024
Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter studyBerenice Anabel Silva, Esteban Miglietta, Juan Cruz Casabona, et al.
Multiple Sclerosis and Related Disorders|May 23, 2020
Consensus recommendations for family planning and pregnancy in multiple sclerosis in argentinaNora Fernández Liguori, Ricardo Alonso, Amelia Alves Pinheiro, et al.
Multiple Sclerosis and Related Disorders|September 3, 2022
Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEMJuan I Rojas, Geraldine G Luetic, Carlos Vrech, et al.
Pageof 3